Mass drug administration for malaria

Cochrane Database of Systematic Reviews

Volumn 2021, Issue 9, 2021, Pages

  Shah, Monica P ^a   Hwang, Jimee ^a,b   Choi, Leslie ^c   Lindblade, Kim A ^a   Kachur, S Patrick ^d   Desai, Meghna ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; AMODIAQUINE PLUS PRIMAQUINE; ARTEMISININ DERIVATIVE; ARTEMISININ PLUS PIPERAQUINE; ARTESUNATE; CHLOROQUINE; CHLOROQUINE PLUS PRIMAQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; PLACEBO; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; TAFENOQUINE; UNCLASSIFIED DRUG;

ABNORMAL URINE COMPOSITION; ANEMIA; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BURKINA FASO; CAMBODIA; COMMON COLD; DIARRHEA; DIZZINESS; DRY COUGH; ENDEMIC DISEASE; FEVER; GASTRITIS; HEADACHE; HUMAN; INCIDENCE; INDOOR RESIDUAL SPRAYING; INFECTION CONTROL; KENYA; LAOS; MALARIA; MALARIA FALCIPARUM; MASS DRUG ADMINISTRATION; MYANMAR; NAUSEA; NIGERIA; NONHUMAN; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PNEUMONIA; PREVALENCE; PRURITUS; RISK ASSESSMENT; RISK REDUCTION; SKIN MANIFESTATION; STOMACH PAIN; SYSTEMATIC REVIEW; TANZANIA; TREATMENT DURATION; TREATMENT OUTCOME; VIET NAM; VOMITING; ZAMBIA;

EID: 85116210548     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008846.pub3     Document Type: Article

References (97)

1. Bennett A, Porter TR, Mwenda MC, Yukich JO, Finn TP, Lungu C, et al. A longitudinal cohort to monitor malaria infection incidence during mass drug administration in Southern Province, Zambia. American Journal of Tropical Medicine and Hygiene 2020;103(2_Suppl):54-65. x-wiley/crsRef/16937797 [DOI: 10.4269/ajtmh.19-0657]
2. Chalwe V, Silumbe K, Finn TP, Hamainza B, Porter T, Kamuliwo M, et al. Adverse event reporting from malaria mass drug administration rounds conducted in Southern Zambia. American Journal of Tropical Medicine and Hygiene 2016;95(5 Supplement 1):487. x-wiley/crsRef/16937798
3. Conner R, Mudenda M, Hamainza B, Moonga H, Miller JM, Eisele TP, et al. Programmatic mass drug administration in Southern Province, Zambia: An evaluation of impact and possible spill-over effects using dhis2 malaria case incidence data. American Journal of Tropical Medicine and Hygiene 2017;97(5 Supplement 1):501. x-wiley/crsRef/16937799
4. Eisele TP, Bennett A, Silumbe K, Finn TP, Porter TR, Chalwe V, et al. Impact of four rounds of mass drug administration with dihydroartemisinin–piperaquine implemented in southern province, Zambia. American Journal of Tropical Medicine and Hygiene 2020;103(2_Suppl):7-18. x-wiley/crsRef/16937800 [DOI: 10.4269/ajtmh.19-0659]
5. Eisele TP, Bennett A, Silumbe K, Finn T, Chalwe V, Kamuliwo M, et al. The impact of targeted mass drug administration using dihydroartemisinin-piperaquine in southern province Zambia: initial findings. American Journal of Tropical Medicine and Hygiene 2015;93(4 Supplement):83. x-wiley/crsRef/16937801
6. Eisele TP, Bennett A, Silumbe K, Finn TP, Chalwe V, Kamuliwo M, et al. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in southern province Zambia: a cluster-randomized controlled trial. Journal of Infectious Diseases 2016;214(12):1831-9. x-wiley/crsRef/16937802
7. Eisele TP, Silumbe K, Finn T, Chalwe V, Kamuliwo M, Hamainza B, et al. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial. Trials 2015;16:347. x-wiley/crsRef/16937803 [DOI: 10.1186/s13063-015-0862-3]
8. Mwenda M, Chishimba S, Mambwe B, Mulube C, Chalwe V, Moonga H, et al. PCR incidence of plasmodium falciparum infections in cohort samples over time during a malaria MDA randomized control trial in southern province Zambia. American Journal of Tropical Medicine and Hygiene 2017;97(5 Supplement 1):593. x-wiley/crsRef/16937804
9. Bennett A, Porter TR, Mwenda MC, Yukich JO, Finn TP, Lungu C, et al. A longitudinal cohort to monitor malaria infection incidence during mass drug administration in southern province, Zambia. American Journal of Tropical Medicine and Hygiene 2020;103(2_Suppl):54-65. x-wiley/crsRef/16937807 [DOI: 10.4269/ajtmh.19-0657]
10. Chalwe V, Silumbe K, Finn TP, Hamainza B, Porter T, Kamuliwo M, et al. Adverse event reporting from malaria mass drug administration rounds conducted in Southern Zambia. American Journal of Tropical Medicine and Hygiene 2016;95(5 Supplement 1):487. x-wiley/crsRef/16937808
11. Conner R, Mudenda M, Hamainza B, Moonga H, Miller JM, Eisele TP, et al. Programmatic mass drug administration in southern province, Zambia: an evaluation of impact and possible spill-over effects using dhis2 malaria case incidence data. American Journal of Tropical Medicine and Hygiene 2017;97(5 Supplement 1):501. x-wiley/crsRef/16937809
12. Eisele TP, Bennett A, Silumbe K, Finn TP, Porter TR, Chalwe V, et al. Impact of four rounds of mass drug administration with dihydroartemisinin–piperaquine implemented in southern province, Zambia. American Journal of Tropical Medicine and Hygiene 2020;103(2_Suppl):7-18. x-wiley/crsRef/16937810 [DOI: 10.4269/ajtmh.19-0659]
13. Eisele TP, Bennett A, Silumbe K, Finn T, Chalwe V, Kamuliwo M, et al. The impact of targeted mass drug administration using dihydroartemisinin-piperaquine in southern province Zambia: initial findings. American Journal of Tropical Medicine and Hygiene 2015;93(4 Supplement):83. x-wiley/crsRef/16937811
14. Eisele TP, Bennett A, Silumbe K, Finn TP, Chalwe V, Kamuliwo M, et al. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in southern province Zambia: a cluster-randomized controlled trial. Journal of Infectious Diseases 2016;214(12):1831-9. x-wiley/crsRef/16937812
15. Eisele TP, Silumbe K, Finn T, Chalwe V, Kamuliwo M, Hamainza B, et al. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in southern province, Zambia: study protocol for a community randomized controlled trial. Trials 2015;16:347. x-wiley/crsRef/16937813
16. Mwenda M, Chishimba S, Mambwe B, Mulube C, Chalwe V, Moonga H, et al. PCR incidence of Plasmodium falciparum infections in cohort samples over time during a malaria MDA randomized control trial in southern province Zambia. American Journal of Tropical Medicine and Hygiene 2017;97(5 Supplement 1):593. x-wiley/crsRef/16937814
17. Escudie A, Hamon J, Schneider J. Results of mass antimalarial chemoprophylaxis with a combination of 4-aminoquinoline and 8-aminoquinoline under rural African conditions in the region of Bobo-Dioulasso (Upper Volta) 1960. Comparative study in a zone treated with DDT and outside this zone. Medecine Tropicale 1962;22(2):268-305. x-wiley/crsRef/16937816
18. Schneider J, Escudie A, Hamon J. Eradication of malaria and chemotherapy. Results obtained with the association amino-4 quinoline + amino-8 quinoline in the pilot area of Bobo-Dioulasso (Haute- Volta) [Eradication du paludismeet chimiotherapie resultats d’un essai de l’association:amino–4 quinoleine/amino–8 quinoleine dans la zonepilote de Bobo–Dioulasso (Haute Volta)]. Bulletin de la Societe de Pathologie Exotique 1961;54(5):1012-25. x-wiley/crsRef/16937817
19. Landier J, Kajeechiwa L, Thwin MM, Parker DM, Chaumeau V, Wiladphaingern J, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar. Wellcome Open Research 2017;2:81. x-wiley/crsRef/16937819
20. von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial. PLoS Medicine 2019;16(2):e1002745. x-wiley/crsRef/16937820
21. Heaton J, McClean A, Swe MM, Soe K, Indrasuta C, Khant ZS, et al. Speeding up malaria elimination; a cluster randomized controlled trial of mass drug administration in Southeast Myanmar, an area with artemisinin resistance. American Journal of Tropical Medicine and Hygiene 2017;97(5 Supplement 1):411. x-wiley/crsRef/17381173
22. McLean AR, Indrasuta C, Khant ZS, Phyo AK, Maung SM, Heaton J, et al. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial. Lancet Infectious Diseases 2021 June 17 [Epub ahead of print]. x-wiley/crsRef/17381174 [DOI: 10.1016/S1473-3099(20)30997-X]
23. Brogger RC, Mathews HM, Storey J, Ashkar TS, Brogger S, Molineaux L. Changing patterns in the humoral immune response to malaria before, during and after the application of control measures: a longitudinal study in the West African savanna. Bulletin of the World Health Organization 1978;56(4):579-600. x-wiley/crsRef/2771739
24. Molineaux L, Brogger RC, Mathews HM, Storey J, Ashkar TS. Longitudinal serological study of malaria in infants in the West African savanna. Comparisons in infants exposed to, or protected from, transmission from birth. Bulletin of the World Health Organisation 1978;56(4):573-8. x-wiley/crsRef/2771740
25. Molineaux L, Gramiccia G. The Garki Project. Research on the epidemiology and control of malaria in the Sudan Savanna of West Africa. 1980. https://apps.who.int/iris/handle/10665/40316 (accessed prior to 8 July 2021). x-wiley/crsRef/2771741
26. Molineaux L, Storey J, Cohen JE, Thomas A. A longitudinal study of human malaria in the West African savanna in the absence of control measures: relationships between different Plasmodium species, in particular P. falciparum and P. malariae. American Journal of Tropical Medicine and Hygiene 1980;29(5):725-37. x-wiley/crsRef/2771742
27. Morris U, Msellem M, Mkali H, Islam A, Aydin-Schmidt B, Jovel I, et al. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting—high coverage and safety, but no significant impact on transmission. BMC Medicine 2018;16:215. x-wiley/crsRef/16937824 [DOI: 10.1186/s12916-018-1202-8]
28. Pongvongsa T, Phommasone K, Adhikari B, Henriques G, Chotivanich K, Hanboonkunupakarn B, et al. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos. Malaria Journal 2018;17(1):405. x-wiley/crsRef/16937827
29. von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial. PLoS Medicine 2019;16(2):e1002745. x-wiley/crsRef/16937828
30. Roberts JM. Pyrimethamine (Daraprim) in the control of epidemic malaria. American Journal of Tropical Medicine and Hygiene 1956;59(9):201-8. x-wiley/crsRef/2771752
31. Roberts JM. The control of epidemic malaria in the highlands of Western Kenya. Part I. Before the campaign. American Journal of Tropical Medicine and Hygiene 1964;67(7):161-8. x-wiley/crsRef/2771753
32. Roberts JM. The control of epidemic malaria in the highlands of Western Kenya. Part II. The campaign. American Journal of Tropical Medicine and Hygiene 1964;67(8):191-9. x-wiley/crsRef/2771754
33. Roberts JM. The control of epidemic malaria in the highlands of Western Kenya. Part III. After the campaign. American Journal of Tropical Medicine and Hygiene 1964;67(9):230-7. x-wiley/crsRef/2771755
34. Shekalaghe SA, Drakeley C, van den Bosch S, ter Braak R, van den Bikilaardt W, Mwanziva C, et al. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malaria Journal 2011;10:247. x-wiley/crsRef/2771759
35. Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijilaardt W, van den Bosch S, et al. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A) individuals. Antimicrobial Agents and Chemotherapy 2010;54(5):1762-8. x-wiley/crsRef/2771760
36. Tripura R, Peto TJ, Chea N, Chan D, Mukaka M, Sirithiranont P, et al. A controlled trial of mass drug administration to interrupt transmission of multidrug-resistant falciparum malaria in Cambodian villages. Clinical Infectious Diseases 2018;67(6):817-26. x-wiley/crsRef/16937830
37. von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial. PLoS Medicine 2019;16(2):e1002745. x-wiley/crsRef/16937831
38. De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. Tropical Medicine & International Health 2001;6(6):442-8. x-wiley/crsRef/2771771
39. von Seidlein L, Walraven G, Milligan PJ, Alexander N, Manneh F, Deen JL, et al. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Transactions of the Royal Society of Tropical Medicine & Hygiene 2003;97(2):217-25. x-wiley/crsRef/2771772
40. von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in South-East Asia: a cluster randomised trial. PLoS Medicine 2019;16(2):e1002745. x-wiley/crsRef/16937833
41. Chakir I, Said AI, Affane B, Jambou R. Control of malaria in the Comoro Islands over the past century. Malaria Journal 2017;16(1):387. x-wiley/crsRef/16937835 [DOI: 10.1186/s12936-017-2027-1]
42. Aregawi M, Smith SJ, Sillah-Kanu M, Seppeh J, Kamara AR, Williams RO, et al. Impact of the mass drug administration for malaria in response to the Ebola outbreak in Sierra Leone. Malaria Journal 2016;15:480. x-wiley/crsRef/16937837
43. Deng C, Huang B, Wang Q, Wu W, Zheng S, Zhang H, et al. Large-scale artemisinin–piperaquine mass drug administration with or without primaquine dramatically reduces malaria in a highly endemic region of Africa. Clinical Infectious Diseases 2018;67(11):1670-6. x-wiley/crsRef/16937839
44. Escudie A, Hamon J, Ricosse JH, Chartol A. Result of two years of antimalarial chemoprophylaxis in rural Africa in the pilot area of ​​Bobo-Dioulasso (Haute Volta) [Resultat de deux annees de chimioprophylaxie antipaludique en milieu rural africain dans la zone-pilote de Bobo-Dioulasso (Haute-Volta)]. Medecine Tropicale 1961;21(Numero special):689-728. x-wiley/crsRef/16937841
45. Fraser M, Miller JM, Silumbe K, Hainsworth M, Mudenda M, Hamainza B, et al. Evaluating the impact of programmatic mass drug administration for malaria in Zambia using routine incidence data. Journal of Infectious Diseases 2020 July 21 [Epub ahead of print]. x-wiley/crsRef/16937843 [DOI: 10.1093/infdis/jiaa434]
46. Aide P, Candrinho B, Galatas B, Munguambe K, Guinovart C, Luis F, et al. Setting the scene and generating evidence for malaria elimination in Southern Mozambique. Malaria Journal 2019;18(1):190. x-wiley/crsRef/16937845 [DOI: https://doi.org/10.1186/s12936-019-2832-9]
47. Galatas B, Saúte F, Martí-Soler H, Guinovart C, Nhamussua L, Simone W, et al. A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study. PLoS Medicine 2020;17(8):e1003227. x-wiley/crsRef/16937846
48. Jones SA. Mass treatment with pyrimethamine: a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya. September 1952-September 1953. Transactions of the Royal Society of Tropical Medicine and Hygiene 1958;52(6):547-61. x-wiley/crsRef/16937848
49. Kagaya W, Chan C, Gitaka J, Kongere J, Idris Z, Deng C, et al. The impact of mass drug administration on submicroscopic malaria infection: A pilot study on Ngodhe Island in Lake Victoria, Kenya. American Journal of Tropical Medicine and Hygiene 2017;97(5 Supplement 1):101. x-wiley/crsRef/16937851
50. Kagaya W, Gitaka J, Chan CW, Kongere J, Idris ZM, Deng C, et al. Malaria resurgence after significant reduction by mass drug administration on Ngodhe Island, Kenya. Scientific Reports 2019;9(1):19060. x-wiley/crsRef/16937850
51. Kaneko A, Chan C, Isozumi R, Kalkoa M, Chaves LF, Watanabe N, et al. Sustainable malaria elimination on Aneityum Island, Vanuatu, 1991-2014. American Journal of Tropical Medicine and Hygiene 2014;91(5 Supplement 1):197. x-wiley/crsRef/16937853
52. Kaneko A, Chan C, Taleo G, Watanabe N, Kalkoa M, Iamar S, et al. Community-directed malaria freedom on Aneityum Island, Vanuatu, 1991-2014. Malaria Journal 2014;13(Supplement 1):P50. x-wiley/crsRef/16937854
53. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet 2000;356(9241):1560-4. x-wiley/crsRef/16937855
54. Landier J, Parker DM, Thu AM, Kajeechiwa L, Twin MM, Proux S, et al. Relative contribution of generalized early diagnosis and treatment and of targeted mass treatment to elimination of Plasmodium falciparum malaria in Eastern Myanmar. American Journal of Tropical Medicine and Hygiene 2016;95(5 Supplement 1):381. x-wiley/crsRef/16937857
55. Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, et al. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. Lancet 2018;391(10133):1916-26. x-wiley/crsRef/16937858
56. Parker DM, Landier J, Thu AM, Lwin KM, Delmas G, Nosten FH, et al. Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar (study protocol: version 2). Wellcome Open Research 2017;2:98. x-wiley/crsRef/16937859
57. Mwesigwa J, Achan J, Affara M, Sainey C, Worwui A, Grietens KP, et al. Impact of mass drug administration with dihydroartemisinin-piperaquine on malaria transmission in a highly seasonal transmission setting in the Gambia. American Journal of Tropical Medicine and Hygiene 2016;95 (5 Supplement 1):1218. x-wiley/crsRef/16937861
58. Mwesigwa J, Achan J, Affara M, Wathuo M, Worwui A, Muhommed N, et al. Mass drug administration with dihydroartemisinin-piperaquine and malaria transmission dynamics in The Gambia - a prospective cohort study. Clinical Infectious Diseases 2018;69(2):278–86. x-wiley/crsRef/16937862 [DOI: 10.1093/cid/ciy870]
59. Mwesigwa J, Achan J, Worwui A, Van Geertruyden J, D’Alessandro U. Impact of two annual cycles of mass drug administration on temporal trends of clinical malaria. American Journal of Tropical Medicine and Hygiene 2017;97(5 Supplement 1):411. x-wiley/crsRef/16937863
60. Najera JA, Shidrawi GR, Storey J, Lietaert PE. Mass drug administration and DDT indoor-spraying as antimalarial measures in the northern savanna of Nigeria. World Health Organization 1973;73(817):1-34. x-wiley/crsRef/16937865
61. Singh J, Misra BG, Ray AP. Suppressive treatment with amodiaquin. Indian Journal of Malariology 1953;7(1):27-31. x-wiley/crsRef/16937867
62. NCT00646126. Antimalarial treatments for clearing low density P. falciparum and its impact on malaria transmission. clinicaltrials.gov/ct2/show/NCT00646126 (first received 28 March 2008). x-wiley/crsRef/18201552
63. ChiCTR-POC-16009019. Protocol of study on the therapeutic tolerability of Artequick/Femse/Togo. chictr.org.cn/showprojen.aspx?proj=15217 (first received 13 August 2016). x-wiley/crsRef/18201553
64. Alonso P, Engels D, Reeder J. Renewed push to strengthen vector control globally. Lancet 2017;389(10086):2270-1.
65. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;54(4):401-6.
66. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 2015;526:207-11.
67. Brady OJ, Slater HC, Pemberton-Ross P, Wenger E, Maude RJ, Ghani AC, et al. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Global Health 2017;5(7):e680-7.
68. Chaccour C, Lines J, Whitty CJ. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. Journal of Infectious Diseases 2010;202(1):113-6.
69. de Souza DK, Thomas R, Bradley J, Leyrat C, Boakye DA, Okebe J. Ivermectin treatment in humans for reducing malaria transmission. Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No: CD013117. [DOI: 10.1002/14651858.CD013117.pub2]
70. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356(9237):1255-9.
71. Eisele, TP. Mass drug administration can be a valuable addition to the malaria elimination toolbox. Malaria Journal 2019;18:281.
72. Garfield RM, Vermund SH. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet 1983;2(8348):500-3.
73. GlaxoSmithKline (GSK). Product label for Krintafel; patient information approved by the US Food and Drug Administration; July 2018. Available at www.accessdata.fda.gov/drugsatfda_docs/label/2018/210795s000lbl.pdf.
74. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. American Journal of Tropical Medicine and Hygiene 2004;70(1):1-7.
75. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 2011;64(4):380-2.
76. Higgins JP, Deeks JJ, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
77. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
78. Hotez PJ. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clinical Pharmacology & Therapeutics 2009;85(6):659-64.
79. Kuehne A, Tiffany E, Lasry E, Janssens M, Besse C, Okonto C, et al. Impact and lessons learned from mass drug administrations of malaria chemoprevention during the Ebola outbreak in Monrovia, Liberia, 2014. PLoS One 2016;11(8):e0161311. [DOI: 10.1371/journal.pone.0161311]
80. Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Review of Anti-infective Therapy 2013;11(6):623-639.
81. Mendis K. Mass drug administration should be implemented as a tool to accelerate elimination: against. Malaria Journal 2019;18:279.
82. Molineaux L, Gramiccia G. The Garki Project: research on the epidemiology and control of malaria in the Sudan Savanna of West Africa; World Health Organization (WHO) 1980. Available at apps.who.int/iris/bitstream/handle/10665/40316/9241560614.pdf?sequence=1&isAllowed=y.
83. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. American Journal of Tropical Medicine and Hygiene 2015;93(1):125-134.
84. Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White MJ, et al. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS ONE 2011;6(5):1-11.
85. Okell LC, Bousema T, Griffin JT, Ouédraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nature Communications 2012;3:1237.
86. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.4.1. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.
87. Richardson M, Garner P, Donegan S. Cluster randomised trials in Cochrane Reviews: evaluation of methodological and reporting practice. PLoS One 2016;11(3):e0151818. [DOI: 10.1371/journal.pone.0151818]
88. Shanks GD. Control and elimination of Plasmodium vivax. Advances in Parasitology 2012;80:301-41.
89. von Seidlein L, Greenwood BM. Mass administration of antimalaria drugs. Trends in Parasitology 2003;19(10):452-60.
90. World Health Organization. The role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria; WHO; November 2015. Available at www.who.int/malaria/publications/atoz/role-of-mda-for-malaria.pdf?ua=1.
91. World Health Organization. Policy brief on single-dose primaquine as a gametocytocide in Plasmodium falciparum malaria; WHO; January 2015. Available at www.who.int/malaria/publications/atoz/who_htm_gmp_2015.1.pdf.
92. World Health Organization. Annex 1. Defining the term "malaria case"; WHO Malaria Policy Advisory Committee Meeting; August 2015. Available at www.who.int/malaria/mpac/mpac-sept2015-terminology-annex1.pdf?ua=1.
93. World Health Organization. A framework for malaria elimination; WHO; March 2017. Available at apps.who.int/iris/bitstream/handle/10665/254761/9789241511988-eng.pdf?sequence=1.
94. World Health Organization. World malaria report 2020: 20 years of global progress and challenges; WHO; 2020. Available at www.who.int/publications/i/item/9789240015791.
95. World Health Organization. Improving WHO's malaria policy-making and dissemination processes; WHO; July 2020. Available at www.who.int/malaria/policy/overview/en/.
96. Poirot E, Hwang J, Kachur SP, Slutsker L, Skarbinski J. Mass drug administration for malaria. Cochrane Database of Systematic Reviews 2010, Issue 11. Art. No: CD008846. [DOI: 10.1002/14651858.CD008846]
97. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database of Systematic Reviews 2013, Issue 12 10.1002/14651858.CD008846.pub2 10.1002/14651858.CD008846.pub2. Art. No: CD008846. [DOI: 10.1002/14651858.CD008846.pub2]